138 related articles for article (PubMed ID: 21074902)
1. Analysis of optineurin in frontotemporal lobar degeneration.
Rollinson S; Bennion J; Toulson G; Halliwell N; Usher S; Snowden J; Richardson A; Neary D; Mann D; Pickering-Brown SM
Neurobiol Aging; 2012 Feb; 33(2):425.e1-2. PubMed ID: 21074902
[TBL] [Abstract][Full Text] [Related]
2. Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease.
Pottier C; Bieniek KF; Finch N; van de Vorst M; Baker M; Perkersen R; Brown P; Ravenscroft T; van Blitterswijk M; Nicholson AM; DeTure M; Knopman DS; Josephs KA; Parisi JE; Petersen RC; Boylan KB; Boeve BF; Graff-Radford NR; Veltman JA; Gilissen C; Murray ME; Dickson DW; Rademakers R
Acta Neuropathol; 2015 Jul; 130(1):77-92. PubMed ID: 25943890
[TBL] [Abstract][Full Text] [Related]
3. Optineurin inclusions occur in a minority of TDP-43 positive ALS and FTLD-TDP cases and are rarely observed in other neurodegenerative disorders.
Hortobágyi T; Troakes C; Nishimura AL; Vance C; van Swieten JC; Seelaar H; King A; Al-Sarraj S; Rogelj B; Shaw CE
Acta Neuropathol; 2011 Apr; 121(4):519-27. PubMed ID: 21360076
[TBL] [Abstract][Full Text] [Related]
4. [Pathomechanisms and clinical aspects of frontotemporal lobar degeneration].
Bürger K; Arzberger T; Stephan J; Levin J; Edbauer D
Nervenarzt; 2017 Feb; 88(2):163-172. PubMed ID: 27999880
[TBL] [Abstract][Full Text] [Related]
5. Screening for OPTN mutations in a cohort of British amyotrophic lateral sclerosis patients.
Johnson L; Miller JW; Gkazi AS; Vance C; Topp SD; Newhouse SJ; Al-Chalabi A; Smith BN; Shaw CE
Neurobiol Aging; 2012 Dec; 33(12):2948.e15-7. PubMed ID: 22892313
[TBL] [Abstract][Full Text] [Related]
6. Novel deletion mutations of OPTN in amyotrophic lateral sclerosis in Japanese.
Iida A; Hosono N; Sano M; Kamei T; Oshima S; Tokuda T; Nakajima M; Kubo M; Nakamura Y; Ikegawa S
Neurobiol Aging; 2012 Aug; 33(8):1843.e19-24. PubMed ID: 22402017
[TBL] [Abstract][Full Text] [Related]
7. Screening for C9ORF72 repeat expansion in FTLD.
Ferrari R; Mok K; Moreno JH; Cosentino S; Goldman J; Pietrini P; Mayeux R; Tierney MC; Kapogiannis D; Jicha GA; Murrell JR; Ghetti B; Wassermann EM; Grafman J; Hardy J; Huey ED; Momeni P
Neurobiol Aging; 2012 Aug; 33(8):1850.e1-11. PubMed ID: 22459598
[TBL] [Abstract][Full Text] [Related]
8. C9orf72 mutations may be rare in frontotemporal lobar degeneration patients in India.
Mukherjee O; Das G; Sen S; Dutt A; Alladi S; Ghosh A
Amyotroph Lateral Scler Frontotemporal Degener; 2015; 17(1-2):151-3. PubMed ID: 26465714
[No Abstract] [Full Text] [Related]
9. A novel optineurin truncating mutation and three glaucoma-associated missense variants in patients with familial amyotrophic lateral sclerosis in Germany.
Weishaupt JH; Waibel S; Birve A; Volk AE; Mayer B; Meyer T; Ludolph AC; Andersen PM
Neurobiol Aging; 2013 May; 34(5):1516.e9-15. PubMed ID: 23062601
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the hexanucleotide repeat in C9ORF72 in Alzheimer's disease.
Rollinson S; Halliwell N; Young K; Callister JB; Toulson G; Gibbons L; Davidson YS; Robinson AC; Gerhard A; Richardson A; Neary D; Snowden J; Mann DM; Pickering-Brown SM
Neurobiol Aging; 2012 Aug; 33(8):1846.e5-6. PubMed ID: 22410647
[TBL] [Abstract][Full Text] [Related]
11. Screening for OPTN mutations in amyotrophic lateral sclerosis in a mainly Caucasian population.
Sugihara K; Maruyama H; Kamada M; Morino H; Kawakami H
Neurobiol Aging; 2011 Oct; 32(10):1923.e9-10. PubMed ID: 21550138
[TBL] [Abstract][Full Text] [Related]
12. Risk genotypes at TMEM106B are associated with cognitive impairment in amyotrophic lateral sclerosis.
Vass R; Ashbridge E; Geser F; Hu WT; Grossman M; Clay-Falcone D; Elman L; McCluskey L; Lee VM; Van Deerlin VM; Trojanowski JQ; Chen-Plotkin AS
Acta Neuropathol; 2011 Mar; 121(3):373-80. PubMed ID: 21104415
[TBL] [Abstract][Full Text] [Related]
13. Genetic analysis of matrin 3 gene in French amyotrophic lateral sclerosis patients and frontotemporal lobar degeneration with amyotrophic lateral sclerosis patients.
Millecamps S; De Septenville A; Teyssou E; Daniau M; Camuzat A; Albert M; LeGuern E; Galimberti D; ; Brice A; Marie Y; Le Ber I
Neurobiol Aging; 2014 Dec; 35(12):2882.e13-2882.e15. PubMed ID: 25158920
[TBL] [Abstract][Full Text] [Related]
14. Low prevalence of progranulin mutations in Finnish patients with frontotemporal lobar degeneration.
Krüger J; Kaivorinne AL; Udd B; Majamaa K; Remes AM
Eur J Neurol; 2009 Jan; 16(1):27-30. PubMed ID: 19049508
[TBL] [Abstract][Full Text] [Related]
15. Frontotemporal lobar degeneration genome wide association study replication confirms a risk locus shared with amyotrophic lateral sclerosis.
Rollinson S; Mead S; Snowden J; Richardson A; Rohrer J; Halliwell N; Usher S; Neary D; Mann D; Hardy J; Pickering-Brown S
Neurobiol Aging; 2011 Apr; 32(4):758.e1-7. PubMed ID: 21257233
[TBL] [Abstract][Full Text] [Related]
16. Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration.
van der Zee J; Van Langenhove T; Kovacs GG; Dillen L; Deschamps W; Engelborghs S; Matěj R; Vandenbulcke M; Sieben A; Dermaut B; Smets K; Van Damme P; Merlin C; Laureys A; Van Den Broeck M; Mattheijssens M; Peeters K; Benussi L; Binetti G; Ghidoni R; Borroni B; Padovani A; Archetti S; Pastor P; Razquin C; Ortega-Cubero S; Hernández I; Boada M; Ruiz A; de Mendonça A; Miltenberger-Miltényi G; do Couto FS; Sorbi S; Nacmias B; Bagnoli S; Graff C; Chiang HH; Thonberg H; Perneczky R; Diehl-Schmid J; Alexopoulos P; Frisoni GB; Bonvicini C; Synofzik M; Maetzler W; vom Hagen JM; Schöls L; Haack TB; Strom TM; Prokisch H; Dols-Icardo O; Clarimón J; Lleó A; Santana I; Almeida MR; Santiago B; Heneka MT; Jessen F; Ramirez A; Sanchez-Valle R; Llado A; Gelpi E; Sarafov S; Tournev I; Jordanova A; Parobkova E; Fabrizi GM; Testi S; Salmon E; Ströbel T; Santens P; Robberecht W; De Jonghe P; Martin JJ; Cras P; Vandenberghe R; De Deyn PP; Cruts M; Sleegers K; Van Broeckhoven C
Acta Neuropathol; 2014 Sep; 128(3):397-410. PubMed ID: 24899140
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the PFN1 gene are not a common cause in patients with amyotrophic lateral sclerosis and frontotemporal lobar degeneration in France.
Lattante S; Le Ber I; Camuzat A; Brice A; Kabashi E
Neurobiol Aging; 2013 Jun; 34(6):1709.e1-2. PubMed ID: 23182804
[TBL] [Abstract][Full Text] [Related]
18. Familial Lund frontotemporal dementia caused by C9ORF72 hexanucleotide expansion.
Englund E; Gustafson L; Passant U; Majounie E; Renton AE; Traynor BJ; Rohrer JD; Mok K; Hardy J
Neurobiol Aging; 2012 Aug; 33(8):1850.e13-6. PubMed ID: 22483864
[TBL] [Abstract][Full Text] [Related]
19. The NOS3 G894T (Glu298Asp) polymorphism is a risk factor for frontotemporal lobar degeneration.
Venturelli E; Villa C; Fenoglio C; Clerici F; Marcone A; Ghidoni R; Cortini F; Scalabrini D; Gallone S; Rainero I; Mandelli A; Restelli I; Binetti G; Cappa S; Mariani C; Giordana MT; Bresolin N; Scarpini E; Galimberti D
Eur J Neurol; 2009 Jan; 16(1):37-42. PubMed ID: 19087148
[TBL] [Abstract][Full Text] [Related]
20. Identification of 2 Loci at chromosomes 9 and 14 in a multiplex family with frontotemporal lobar degeneration and amyotrophic lateral sclerosis.
Gijselinck I; Engelborghs S; Maes G; Cuijt I; Peeters K; Mattheijssens M; Joris G; Cras P; Martin JJ; De Deyn PP; Kumar-Singh S; Van Broeckhoven C; Cruts M
Arch Neurol; 2010 May; 67(5):606-16. PubMed ID: 20457961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]